Candidiasis, Invasive Recruiting Phase 3 Trials for MK-3118 (DB12471)

Also known as: Invasive Candidiasis / Systemic moniliasis / Systemic candida / Disseminated candidiasis / Disseminated candida / Systemic candidiasis

IndicationStatusPhase
DBCOND0036184 (Candidiasis, Invasive)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03363841Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)Treatment
NCT03059992Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal TreatmentTreatment